Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects diagnosed with dyslipidemia Serum cholesterol levels 200 - 299mg/dl and/or Serum triglyceride levels 150 - 499mg/dl and/or Serum LDL cholesterol levels 130- 189 mg/dl and/or Serum VLDL cholesterol levels 30 - 60mg/dl Serum HDL cholesterol levels Subjects fit for Virechana and udvartana. Subject who submits and accepts a written informed consent. Not undergoing in any other Clinical trials. Individuals with normal Homocysteine (5-15Mcmol/L) levels will be included in Control group.
Exclusion criteria
Exclusion criteria: Patients with history of serious cardiac problems as Myocardial Infarction, malignant hypertension, cardiac failure. Patients having major illness like insulin dependent diabetes mellitus and chronic uncontrolled type II diabetes mellitus. Patients with history of any serious renal disorder. Patients having Thyroid Disorders. Drug induced Hyperlipidemia e.g. â?? Glucocorticoid induced. Pregnant and lactating females Subjects unfit for Virechana and udvartana. Subjects with Homocysteine >15Mcmol/L levels will be excluded from in Control group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 10% Reduction in Serum Lipid Profile Timepoint: 0th day, 8th day, 18th day and 25th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in Weight BMI Anthropometric measurements â?? Abdominal circumference, Chest circumference, hip circumference, mid-thigh and mid-arm circumference KARADA scan Skin fold thickness (using skin fold caliper) - Triceps, Mid axillary, subscapular, abdominal, Thigh. Timepoint: 0th day, 8th day, 18th day and 25th day | — |
Countries
India
Contacts
Rajiv Gandhi education societys Ayurvedic Medical college and Hospital